Skip to content

Long term analgesic advantages and safety analysis of bupivacaine liposomes compared to ropivacaine in postoperative analgesia after pelvic floor reconstruction surgery

Long term analgesic advantages and safety analysis of liposomes bupivacaine compared to ropivacaine in postoperative analgesia after pelvic floor reconstruction surgery

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600121064
Enrollment
Unknown
Registered
2026-03-25
Start date
2025-08-13
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pelvic floor dysfunctionchronic pelvic pain

Interventions

Sponsors

Peking University People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
30 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1.Meets surgical indications and has surgical intention; 2.Can tolerate surgery and anesthesia; 3.No related malignant diseases; 4.Sign relevant informed consent forms; 5.age from 30 to 85; 6.Patients with good treatment compliance and complete clinical data;

Exclusion criteria

Exclusion criteria: 1.Contraindications for NSAIDs medication; 2.hose who do not meet the indications for the use of ropivacaine and bupivacaine liposomes; 3.Individuals with absolute contraindications to surgery or anesthesia; 4.Acute phase of various diseases, patients with mental illnesses; 5.Incomplete clinical medical records, failure to follow up according to medical advice, or loss of follow-up patients for various reasons;

Design outcomes

Primary

MeasureTime frame
Dynamic Visual Analog Scale (VAS) for rest and movement pain at postoperative immediate, 24, 48, and 72 hours;

Secondary

MeasureTime frame
Time to first ambulation after surgery;Time interval to first rescue analgesia;Total consumption of opioid analgesics within 72 hours for rescue pain relief;Visual Analog Scale (VAS) for movement-induced pain;

Countries

China

Contacts

Public ContactXie Bing

Peking University People's Hospital

258159806@qq.com+86 10 88324523

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 4, 2026